Welcome to 'Big Deal', Tech.eu's weekly feature that takes a closer look at some of the most significant funding and exit deals in European Tech.
This week, we're putting “data orchestration and workflow software for life sciences” Seqera Labs under the microscope and aim to dissect just where the company came from, what part it played in the fight against Covid-19, and what an Addition led €22 million investment round means for the company.
Moreover, instead of just the written word, we managed to sit down with Seqera Labs' CEO and co-founder Evan Floden and hit the record button.
Continue reading this article by becoming a Tech.eu Insider
If you are a member of Tech.eu Insights, you can log in to access the full article. If you don't have Insights access yet, you can act now.
Sign in
or
Would you like to write the first comment?
Login to post comments